rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    DCTH
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Delcath: A Profitable Core Business With Transformative Pipeline Potential (Rating Downgrade)

      Delcath stock is downgraded to a hold, as upside may need colorectal and breast cancer trial success, with colorectal data due mid-2027.

      18h agoSeeking AlphaDCTH
      Delcath Systems director Bridget Martell sells $488,508 in stock
      Nov 13Investing.comDCTH
      Delcath Systems (DCTH) is on the Move, Here's Why the Trend Could be Sustainable
      Nov 13Yahoo FinanceDCTH
      BTIG sees upside across medtech stocks as iRhythm, Delcath and MiniMed stand out
      Nov 12Investing.comDCTHIRTC
      Delcath Systems stock rating reiterated at Buy by BTIG
      Nov 12Investing.comDCTH
      Wall Street Analysts Think Delcath Systems (DCTH) Could Surge 27.7%: Read This Before Placing a Bet
      Nov 12Yahoo FinanceDCTH
      Delcath Systems to Be Featured on "Health Uncensored with Dr. Drew" in Segment Highlighting Advances in Liver-Directed Cancer Treatment
      Nov 11Yahoo FinanceDCTH
      Delcath Systems, Inc. Q3 2026 Earnings Call Summary
      Nov 9Yahoo FinanceDCTH
      Crude Oil Falls Over 3%; NRG Energy Shares Jump After Strong Q3 Results
      Nov 9BenzingaDCTHZURANRG
      BTIG raises Delcath Systems stock price target to $25 on strong Q3 results
      Nov 9Investing.comDCTH
      Delcath Systems Reports 70% Revenue Growth in Q3 2026 and Raises Full-Year Guidance to $115 Million–$117 Million
      Nov 9Yahoo FinanceDCTH
      Delcath Systems earnings beat by $0.26, revenue topped estimates
      Nov 9Investing.comDCTH
      Delcath Systems Q3 Earnings Call Highlights
      Nov 9Yahoo FinanceDCTH
      Delcath Systems Q3 2026 Earnings Call Transcript
      Nov 9BenzingaDCTH
      Delcath Systems, Inc. (DCTH) Q3 Earnings and Revenues Top Estimates
      Nov 9Yahoo FinanceDCTH
      Delcath Systems Reports Third Quarter 2026 Results and Business Highlights
      Nov 9Yahoo FinanceDCTH
      Delcath Systems Stock: Intriguingly Poised Ahead Of Q3 Earnings (NASDAQ:DCTH)

      Delcath Systems Q3 earnings preview: topline beat odds look strong as CHOPIN trial success boosts growth outlook. Read here for more on DCTH stock.

      Nov 4Seeking AlphaDCTH
      Delcath Systems to Participate in Upcoming Investor Conferences
      Oct 27Yahoo FinanceDCTH
      Delcath Systems to Host Third Quarter 2026 Earnings Call

      QUEENSBURY, N.Y., October 26, 2026--Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced today it will host a conference call on November 9, 2026, at 8:30 AM Eastern Time to discuss results for its third quarter ended September 30, 2026.

      Oct 26Yahoo FinanceDCTH
      Delcath to present cancer treatment data at ESMO conference
      Oct 19Investing.comDCTH
      Delcath Systems Highlights Clinical Program Presentations at ESMO Congress 2026 and Independent Data on Percutaneous Hepatic Perfusion in Liver-Dominant Metastatic Uveal Melanoma
      Oct 19Yahoo FinanceDCTH
      Delcath Systems Q2 2026 Earnings Call Transcript - Delcath Systems (NASDAQ:DCTH)

      Delcath Systems (NASDAQ:DCTH) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. Benzinga APIs provide real-time access to

      Oct 6BenzingaDCTH
      Are Medical Stocks Lagging Delcath Systems (DCTH) This Year?

      Here is how Delcath Systems, Inc. (DCTH) and Encompass Health (EHC) have performed compared to their sector so far this year.

      Sep 15Yahoo FinanceDCTH
      Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

      QUEENSBURY, N.Y., September 11, 2026--Delcath Systems, Inc. (Nasdaq: DCTH) (the "Company" or "Delcath"), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that the Company granted equity awards, previously approved by the Company’s Compensation Committee, as material inducements to four individuals whose employment commenced in either July 2026 or August 2026.

      Sep 11Yahoo FinanceDCTH
      Delcath’s (DCTH) Liver Cancer Device Keeps Growing, But At A Cost

      On August 6, Delcath Systems (NASDAQ:DCTH) reported second-quarter results that showed the company selling more of its liver cancer treatment than ever, even as the cost of running the business climbed just as fast. The interventional oncology company posted total revenue of $29.1 million, up from $24.2 million a year earlier, and used the report […]

      Sep 11Yahoo FinanceDCTH
      Zacks.com featured highlights include EuroDry, RCM, Assembly Biosciences, Delcath and National Energy Services

      EuroDry, RCM Technologies, Assembly Biosciences, Delcath Systems and National Energy Services show strong price momentum after August's market gains.

      Sep 8Yahoo FinanceASMBDCTHEDRYNESR
      Delcath Systems to Participate in Upcoming Investor Conferences

      QUEENSBURY, N.Y., August 31, 2026--Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced that management will be attending the following investor conferences:

      Aug 31Yahoo FinanceDCTH
      What Makes Delcath Systems, Inc. (DCTH) a Strong Momentum Stock: Buy Now?

      Does Delcath Systems, Inc. (DCTH) have what it takes to be a top stock pick for momentum investors? Let's find out.

      Aug 28Yahoo FinanceDCTH
      Recent Price Trend in Delcath Systems (DCTH) is Your Friend, Here's Why

      If you are looking for stocks that are well positioned to maintain their recent uptrend, Delcath Systems (DCTH) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

      Aug 28Yahoo FinanceDCTH
      Wall Street Analysts Believe Delcath Systems (DCTH) Could Rally 52.44%: Here's is How to Trade

      The average of price targets set by Wall Street analysts indicates a potential upside of 52.4% in Delcath Systems (DCTH). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

      Aug 27Yahoo FinanceDCTH

      This is the newest page. Registered accounts read further back.